Prognostic Implication of Tumor-Infiltrating Lymphocytes in Patients With HER2-Positive Breast Cancer

被引:0
|
作者
Yoshida, E. J. [1 ]
Li, Q. [1 ]
Chung, A. [1 ]
Knudsen, B. [1 ]
Burnison, M. [1 ]
Mirhadi, A. J. [1 ]
Zumsteg, Z. S. [1 ]
Giuliano, A. E. [1 ]
Amersi, F. F. [1 ]
Shiao, S. L. [1 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词
D O I
10.1016/j.ijrobp.2016.06.118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
98
引用
收藏
页码:S44 / S45
页数:2
相关论文
共 50 条
  • [1] Prognostic value of tumor-infiltrating lymphocytes in small HER2-positive breast cancer
    Criscitiello, C.
    Bagnardi, V.
    Pruneri, G.
    Vingiani, A.
    Esposito, A.
    Rotmensz, N.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
    Luque, Melani
    Sanz-Alvarez, Marta
    Morales-Gallego, Miriam
    Madoz-Gurpide, Juan
    Zazo, Sandra
    Dominguez, Carolina
    Cazorla, Alicia
    Izarzugaza, Yann
    Arranz, Juan Luis
    Cristobal, Ion
    Rojo, Federico
    CANCERS, 2022, 14 (24)
  • [3] Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges
    Schlam, I.
    Loi, S.
    Salgado, R.
    Swain, S. M.
    ESMO OPEN, 2025, 10 (02)
  • [4] Investigating the role of tumor-infiltrating lymphocytes in advanced HER2-positive breast cancer
    Luen, Stephen J.
    Loi, Sherene
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)
  • [5] Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer
    Heppner, Barbara Ingold
    Untch, Michael
    Denkert, Carsten
    Pfitzner, Berit M.
    Lederer, Bianca
    Schmitt, Wolfgang
    Eidtmann, Holger
    Fasching, Peter A.
    Tesch, Hans
    Solbach, Christine
    Rezai, Mahdi
    Zahm, Dirk M.
    Holms, Frank
    Glados, Manfred
    Krabisch, Petra
    Heck, Esther
    Ober, Angelika
    Lorenz, Petra
    Diebold, Kurt
    Habeck, Jorg-Olaf
    Loib, Sibylle
    CLINICAL CANCER RESEARCH, 2016, 22 (23) : 5747 - 5754
  • [6] Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer
    Norie Abe
    Hirofumi Matsumoto
    Reika Takamatsu
    Kentaro Tamaki
    Naoko Takigami
    Kano Uehara
    Yoshihiko Kamada
    Nobumitsu Tamaki
    Tokiwa Motonari
    Mikiko Unesoko
    Norihiro Nakada
    Hisamitsu Zaha
    Naoki Yoshimi
    Virchows Archiv, 2020, 476 : 701 - 709
  • [7] Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer
    Abe, Norie
    Matsumoto, Hirofumi
    Takamatsu, Reika
    Tamaki, Kentaro
    Takigami, Naoko
    Uehara, Kano
    Kamada, Yoshihiko
    Tamaki, Nobumitsu
    Motonari, Tokiwa
    Unesoko, Mikiko
    Nakada, Norihiro
    Zaha, Hisamitsu
    Yoshimi, Naoki
    VIRCHOWS ARCHIV, 2020, 476 (05) : 701 - 709
  • [8] HER2-Positive Breast Cancer: Association of MRI and Clinicopathologic Features With Tumor-Infiltrating Lymphocytes
    Lee, Hyo-Jae
    Lee, Jong Eun
    Jeong, Won Gi
    Ki, So Yeon
    Park, Min Ho
    Lee, Ji Shin
    Nah, Yoo Kyeong
    Lim, Hyo Soon
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 218 (02) : 258 - 269
  • [9] Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer
    Heppner, B. Ingold
    Untch, M.
    Denkert, C.
    Pfitzner, B. M.
    Lederer, B.
    Schmidt, W.
    Eidtmann, H.
    Fasching, P.
    Tesch, H.
    Solbach, C.
    Rezai, M.
    Zahm, D. -M.
    Holms, F.
    Glados, M.
    Krabisch, P.
    Heck, E.
    Ober, A.
    Lorenz, P.
    Diebold, K.
    Habeck, J.
    Loibl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 5 - 5
  • [10] Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
    Kurozumi, Sasagu
    Inoue, Kenichi
    Matsumoto, Hiroshi
    Fujii, Takaaki
    Horiguchi, Jun
    Oyama, Tetsunari
    Kurosumi, Masafumi
    Shirabe, Ken
    SCIENTIFIC REPORTS, 2019, 9 (1)